CAUSES OF MORTALITY FOLLOWING TREATMENT FOR PROSTATE CANCER: WHAT IS THE IMPACT OF ANDROGEN DEPRIVATION?

被引：0
|
作者：
Punnen, Sanoj
Cooperberg, Matthew
Sadetsky, Natalia
Fuldeore, Mahesh
Carroll, Peter
机构：
来源：
JOURNAL OF UROLOGY | 2011年 / 185卷 / 04期
关键词：
D O I：
10.1016/j.juro.2011.02.1689
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
721
引用
收藏
页码：E290 / E290
页数：1
相关论文
共 50 条
  • [21] Androgen deprivation therapy for localized prostate cancer and the risk of cardiovascular mortality
    Tsai, Henry K.
    D'Annico, Anthony V.
    Sadetsky, Natalia
    Chen, Ming-Hui
    Carroll, Peter R.
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2007, 99 (20) : 1516 - 1524
  • [22] Association of androgen deprivation duration and cardiovascular mortality in prostate cancer men
    Yorozu, A.
    Sutani, S.
    Toya, K.
    Shiraishi, Y.
    Saito, S.
    RADIOTHERAPY AND ONCOLOGY, 2019, 133 : S334 - S335
  • [23] Androgen deprivation therapy for the treatment of prostate cancer: a focus on pharmacokinetics
    Polotti, Charles F.
    Kim, Christopher J.
    Chuchvara, Nadiya
    Polotti, Alyssa B.
    Singer, Eric A.
    Elsamra, Sammy
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2017, 13 (12) : 1265 - 1273
  • [24] Immunosuppressive environment in response to androgen deprivation treatment in prostate cancer
    Qin, Caipeng
    Wang, Jing
    Du, Yiqing
    Xu, Tao
    FRONTIERS IN ENDOCRINOLOGY, 2022, 13
  • [25] NEW FORMS OF ANDROGEN DEPRIVATION FOR TREATMENT OF PROSTATE-CANCER
    SOLOWAY, MS
    SOUTHERN MEDICAL JOURNAL, 1986, 79 (09) : 79 - 79
  • [26] Metabolomic effects of androgen deprivation therapy treatment for prostate cancer
    Chi, Jen-Tsan
    Lin, Pao-Hwa
    Tolstikov, Vladimir
    Oyekunle, Taofik
    Chen, Emily Y.
    Bussberg, Valerie
    Greenwood, Bennett
    Sarangarajan, Rangaprasad
    Narain, Niven R.
    Kiebish, Michael A.
    Freedland, Stephen J.
    CANCER MEDICINE, 2020, 9 (11): : 3691 - 3702
  • [27] Can androgen deprivation be considered a primary treatment for prostate cancer?
    David Kirk
    Nature Clinical Practice Urology, 2006, 3 : 126 - 127
  • [28] Intermittent Versus Continuous Androgen Deprivation Treatment of Prostate Cancer
    Zhu, Jianhong
    Zheng, Yayuan
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (31) : 4024 - 4024
  • [29] Can androgen deprivation be considered a primary treatment for prostate cancer?
    Kirk, D
    NATURE CLINICAL PRACTICE UROLOGY, 2006, 3 (03): : 126 - 127
  • [30] Molecular Characterization of Prostate Cancer Following Androgen Deprivation: The Devil in the Details
    Barbieri, Christopher E.
    Rubin, Mark A.
    EUROPEAN UROLOGY, 2014, 66 (01) : 40 - 41
12345